Testing effectiveness (Phase 2)Active Not RecruitingNCT05345522
What this trial is testing
Anti-IL-6R mAb Injection in Patients With iMCD
Who this might be right for
Idiopathic Multicentric Castleman's Disease
Beijing VDJBio Co., LTD. 25
Showing 8 of 8 results